Close Menu

NEW YORK – Roche on Thursday reported a 3 percent decline in half-year revenues for its Diagnostics division. At constant exchange rates, however, diagnostics revenues were up 3 percent, and the main driver of both revenue gains and misses was the COVID-19 pandemic.

For the first half of 2020, the Roche Group reported CHF 29.28 billion ($31.53 billion) in total sales, down 4 percent (up 1 percent at constant exchange rates) from CHF 30.47 billion during the first half of 2019.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to the Wall Street Journal, the Food and Drug Administration may soon issue an Emergency Use Authorization for convalescent plasma to treat COVID-19 patients.

Minnesota police have used genetic genealogy to make an arrest in a 1986 cold case, reports NBC News.

Researchers have used CRISPR-Cas9 to efficiently target a cephalopod pigmentation gene, as they report in Current Biology.

In Science this week: chromatin accessibility of microglia during fetal development, and more.